课题基金 / 基金详情

项目摘要

项目成果

Juan Carlos Ramos的其他基金

相似基金

相关文献

中文摘要
翻译
大学迈阿密(UM)-迈阿密是美国最大的都市区之一, HIV-1感染率。在佛罗里达(全国3 '*^)大约有125,000人感染艾滋病毒, 67%是黑人或西班牙裔(佛罗里达卫生部,艾滋病毒/艾滋病情况说明,2008年)。迈阿密戴德县 占该州艾滋病毒感染者的20%。艾滋病毒/艾滋病是世界上 年龄在25-44岁的非裔美国人。在迈阿密-戴德县,艾滋病毒感染者主要在我们的 附属杰克逊纪念医院(JMH),一个1500张病床的三级设施,为内城,贫困, 少数民族人口和UM的艾滋病临床研究单位(ACRU)由玛格丽特FischI博士指导。更 最近,UM扩大了临床和教学业务,在我们的附近获得了560张床位的设施。 位于迈阿密中心的癌症中心UM/JMH的艾滋病毒方案自20世纪80年代初以来一直存在, 为HIV临床治疗和研究做出了重要贡献。成人艾滋病门诊计划如下 每年约有2,600名感染艾滋病毒的成年人接受8,000多次门诊治疗。约30% 是女性,45%的非洲裔美国人,15%的海裔美国人,30%的西班牙裔美国人,其余的欧洲人, 美国人
英文摘要
University Miami (UM) - Miami is one ofthe largest metropolitan areas in the United States with the highest incidence of HIV-1 infecfion. Approximately 125,000 people are living with HIV in Florida (3'*^ in the nation) and 67% are black or Hispanic (Florida Department of Health, HIV/AIDS Fact Sheet, 2008). Miami Dade County accounts for 20% of those with HIV infection in the state. HIV/AIDS is the number one cause of death in African Americans ages 25-44. In Miami-Dade County, HIV-infected patients are primarily followed at our affiliated Jackson Memorial Hospital (JMH), a 1500-bed tertiary facility that serves an inner-city, indigent, and minority population and at UM's AIDS Clinical Research Unit (ACRU) directed by Dr. Margaret FischI. More recently, UM has expanded its clinical and teaching operations acquiring a 560-bed facility adjacent to our cancer center in the heart of Miami. The HIV program at UM/JMH has existed since the eariy 1980's and has contributed significanfiy to HIV dinical care and research. The adult HIV outpatient program follows approximately 2,600 HIV-infected adult individuals with over 8,000 outpatient visits a year. Approximately 30% are female, 45% African-American, 15% Haifian-American, 30% Hispanic-American, and the remainder Euro- American.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
Epigenetic Targeting of Afro-Caribbean Variant of HTLV-1 Related Adult T-cell Leukemia-lymphoma
University of Miami Core Site
Targeting of EBV Latency in Burkitt's Lymphoma
海外基金